SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
复制标题
DOI:
10.1038/nature15400
复制
发表时间:
2015-10-08
期刊:
影响因子:
64.8
通讯作者:
Göttlinger HG
中科院分区:
文献类型:
--
作者:
Usami Y;Wu Y;Göttlinger HG
HIV-1 Nef and the unrelated murine leukemia virus glycoGag strongly enhance the infectivity of HIV-1 virions produced in certain cell types in a clathrin-dependent manner. Here we show that Nef and glycoGag prevent the incorporation of the multipass transmembrane proteins SERINC3 and SERINC5 into HIV-1 virions to an extent that correlates with infectivity enhancement. Silencing of SERINC3 together with SERINC5 precisely phenocopied the effects of Nef and glycoGag on HIV-1 infectivities. The infectivity of nef-deficient virions increased more than 100-fold when produced in double-knockout human CD4+ T cells that lack both SERINC3 and SERINC5, and re-expression experiments confirmed that the absence of SERINC3 and SERINC5 accounted for the infectivity enhancement. Furthermore, SERINC3 and SERINC5 together restricted HIV-1 replication, and this restriction was evaded by Nef. SERINC3 and SERINC5 are highly expressed in primary human HIV-1 target cells, and inhibiting their downregulation by Nef is a potential strategy to combat HIV/AIDS.